Comparative safety and efficacy of insulin degludec with insulin glargine in type 2 and type 1 diabetes: a meta-analysis of randomized controlled trials

被引：0
|
作者：
Xiao-Wen Zhang
Xin-Lin Zhang
Biao Xu
Li-Na Kang
机构：
[1] Nanjing University School of Medicine,Department of Endocrinology, Affiliated Drum Tower Hospital
[2] Nanjing University School of Medicine,Department of Cardiology, Affiliated Drum Tower Hospital
来源：
Acta Diabetologica | 2018年 / 55卷
关键词：
Insulin degludec; Insulin glargine; Hypoglycemia; Meta-analysis; Randomized controlled trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：429 / 441
页数：12
相关论文
共 50 条
  • [31] Comparison of Insulin Glargine with Insulin Degludec in Type 1 Diabetes Patients
    Kuroda, Akio
    Tsuruo, Miho
    Takeshi, Kondo
    Aki, Nanako
    Oguro, Yukari
    Endo, Itsuro
    Aihara, Ken-ichi
    Tamaki, Motoyuki
    Matsumoto, Toshio
    Matsuhisa, Munehide
    DIABETES, 2014, 63 : A232 - A232
  • [32] REDUCED RISK OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES REQUIRING HIGH DOSES OF BASAL INSULIN: A META-ANALYSIS OF 5 RANDOMIZED BEGIN TRIALS
    Rodbard, Helena W.
    Gough, Stephen
    Lane, Wendy
    Korsholm, Lars
    Bretler, Ditte-Marie
    Handelsman, Yehuda
    ENDOCRINE PRACTICE, 2014, 20 (04) : 285 - 292
  • [33] Efficacy and safety of fixed-ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials
    Wang, Rui
    Luo, Shuoming
    Xiao, Zilin
    Zhou, Zhiguang
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (03)
  • [34] Comparison of the efficacy and safety of insulin degludec between type 1 and type 2 diabetes
    Fujiya, Atsushi
    Shimauchi, Risa
    Kato, Makoto
    Miura, Emiri
    Shibata, Taiga
    Sobajima, Hiroshi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S128 - S128
  • [35] Efficacy and Safety of Insulin Aspart 30 and Insulin Degludec/Aspart vs. Basal Insulin in Patients with Type 2 Diabetes: A Meta-analysis
    Mishriky, Basem M.
    Tanenberg, Robert J.
    Cummings, Doyle M.
    DIABETES, 2017, 66 : A252 - A252
  • [36] Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta-analysis
    Joshi, Shashank R.
    Singh, Gursharan
    Marwah, Ashwani
    Mittra, Shivani
    Suvarna, Viraj R.
    Athalye, Sandeep N.
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1589 - 1606
  • [37] Comparative efficacy and safety of weekly dulaglutide versus weekly insulin in type 2 diabetes: A network meta-analysis of randomized clinical trials
    Ayesh, Hazem
    Suhail, Sajida
    Ayesh, Suhail
    Niswender, Kevin
    METABOLISM OPEN, 2024, 22
  • [38] Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta-analysis of randomized clinical trials
    Ayesh, Hazem
    Suhail, Sajida
    Ayesh, Suhail
    Niswender, Kevin
    DIABETES OBESITY & METABOLISM, 2024, 26 (09): : 3801 - 3809
  • [39] Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials
    Mannucci, Edoardo
    Caiulo, Chiara
    Naletto, Lara
    Madama, Giuseppe
    Monami, Matteo
    ENDOCRINE, 2021, 74 (03) : 508 - 517
  • [40] Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials
    Edoardo Mannucci
    Chiara Caiulo
    Lara Naletto
    Giuseppe Madama
    Matteo Monami
    Endocrine, 2021, 74 : 508 - 517
12345